Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02416401 · ClinicalTrials.gov registry record · NA
Attention Training for Learning Enhancement and Resilience Trial
A NA study of Age-related Cognitive Decline, sponsored by Posit Science Corporation.
- Completed
- Registry status
- NA
- Development phase
- 83
- Enrollment target
- 2
- Study locations
NCT02416401: Completed NA study of Age-related Cognitive Decline, sponsored by Posit Science Corporation.
NCT02416401 is a NA study of Age-related Cognitive Decline that has completed, run by Posit Science Corporation. The registered enrollment target is 83 participants, below the 1,125-participant average among 10 other Age-related Cognitive Decline trials with a reported enrollment target (93% lower). The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02416401, a NA study of Age-related Cognitive Decline, has completed, sponsored by Posit Science Corporation.
- COMPLETED
- Registry status
- NA
- Development phase
- 83 participants
- Enrollment target
- 2
- Study locations
Study Summary
Healthy aging is associated with a decline in multiple cognitive domains, as well as motor control function. The long-term consequences of cognitive and functional impairment resulting from age-related cognitive decline are well documented in the scientific and clinical literature, with significant evidence of related problems with independent functional abilities. This study aims to understand how the experimental computer program can affect cognition and attention in participants with age-related cognitive decline.
Primary Outcome
Measures aimed to test attention
Conditions Studied
Interventions
- OTHER Computerized Plasticity-Based Adaptive Cognitive Training
- OTHER Commercially available computerized training
Study Locations (2)
Iowa
- University of Iowa - Iowa City
Massachusetts
- Harvard Medical School - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 83 participants |
| Start Date | 2015-11 |
| Est. Completion | 2017-12 |
| Phase | NA |
What the finished NCT02416401 record still lists
NCT02416401 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 83 participants, a relatively small participant target, below the 1,125-participant average among 10 other Age-related Cognitive Decline trials with a reported enrollment target (93% lower).
The record links to 1 condition, with Age-related Cognitive Decline appearing as the primary indexed condition, and to 2 interventions - of which Computerized Plasticity-Based Adaptive Cognitive Training is the first listed.
NCT02416401 reports a single indexed study location in Iowa, Massachusetts.
Frequently Asked Questions
What is clinical trial NCT02416401 about?
NCT02416401 is a clinical study titled "Attention Training for Learning Enhancement and Resilience Trial". Healthy aging is associated with a decline in multiple cognitive domains, as well as motor control function. The long-term consequences of cognitive and functional impairment resulting from age-related cognitive decline are well documented in the scientific and clinical literature, with significant ...
What is the current status of trial NCT02416401?
This trial is currently completed. It is a NA study. The enrollment target is 83 participants. The study started on 2015-11. Estimated completion is 2017-12.
What conditions does trial NCT02416401 study?
This clinical trial studies the following conditions: Age-related Cognitive Decline.
What interventions are being tested in trial NCT02416401?
The interventions under investigation include: Computerized Plasticity-Based Adaptive Cognitive Training (OTHER), Commercially available computerized training (OTHER).
Who is sponsoring clinical trial NCT02416401?
This trial is sponsored by Posit Science Corporation, which has 30 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02416401 being conducted?
This trial has 2 study locations across Iowa, Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Age-related Cognitive Decline
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02416401's enrollment target sits among peer trials
83 7th of 10 higher than 4 of 10 other Age-related Cognitive Decline trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Age-related Cognitive Decline trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Feasibility and Adherence to a Technology-assisted Home-based Strength Training Program in Adults With Type 2 Diabetes Mellitus and Mild Cognitive Impairment
RECRUITING · NA
-
The Active Mind Trial: An Adaptive Randomized Trial to Improve Function and Delay Dementia
RECRUITING · NA
-
Cardiac-Control Affecting Learning Through Mindfulness (CALM)
RECRUITING · NA
-
Brain Enhancement Training Towards Elders Resilience to Aging, Phase IIB
COMPLETED · NA
-
Cognitive Multi-Tasking Training in Healthy Older Adults
COMPLETED · NA
-
Effects of Tart Cherry Juice on the Body
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02974647 · 83 participants · Phase 2
Study of Ruxolitinib in Relapsed or Refractory T or NK Cell Lymphoma
- NCT03919292 · 83 participants · Phase 1
Neratinib + Valproate in Advanced Solid Tumors, w/Expansion Cohort in Ras-Mutated Ca
- NCT04626674 · 83 participants · Phase 1
A Gene Transfer Therapy Study to Evaluate the Safety of and Expression From Delandistrogene Moxeparvovec (SRP-9001) in Participants With Duchenne Muscular Dystrophy (DMD)
- NCT05277168 · 83 participants · Phase 1
A Trial TO Evaluate THE Safety, Tolerability, Pharmacokinetics, AND Efficacy OF Shr-a1904 IN Subjects With Advanced Solid Tumors
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia